BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Nosology
,
Lipopolysaccharide
,
rs4950928
,
IL1A
,
Response to oxidative stress
,
Neuron
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
LPS receptor
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
The response of THP-1 cells to treatments with LPS and TGFb1
Macrophages treated with interferon-gamma (IFNG) and lipopolysaccharide (LPS)
Gene expression of PBMCs treated with CpG oligodeoxynucleotides or LPS
Steroid effect on HUVEC response to LPS or cytokines
Primary cortical astrocytes treated with combinations of TGFB, IFNG, and LPS
Explore Curated Studies Results
Literature
Most Relevant Literature
Limited contribution of the of P2X4 receptor to LPS-induced microglial reaction in mice.
Maillard-type glycated collagen with alginate oligosaccharide suppresses inflammation and oxidative …
Stabilin receptors clear LPS and control systemic inflammation.
Cannabinoid receptors modulate LPS-induced increase of class-II transactivator expression levels in …
Modulation of lipopolysaccharide receptor expression by lactate dehydrogenase-elevating virus.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Anti-inflammatory Effects of GTS-21 After LPS
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
LPS and Platelet Activation in Myocardial Infarction
Dose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacit…
Effects of GSK2798745 on Alveolar Barrier Disruption in a Segmental Lipopolysaccharide (LPS) Challen…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ